- Report
- May 2024
- 131 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Report
- May 2024
- 139 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Report
- May 2024
- 130 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Report
- May 2024
- 132 Pages
Global
From €6196EUR$6,499USD£5,281GBP
- Report
- August 2023
- 133 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- July 2023
- 129 Pages
Global
From €7150EUR$7,500USD£6,094GBP
- Report
- April 2019
- 208 Pages
Global
From €2859EUR$2,999USD£2,437GBP
- Report
- February 2021
- 420 Pages
United States
From €1945EUR$2,040USD£1,658GBP
€2288EUR$2,400USD£1,950GBP
- Report
- November 2022
- 100 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- August 2022
- 30 Pages
Global
From €3098EUR$3,250USD£2,641GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €477EUR$500USD£406GBP
- Report
- January 2019
- 35 Pages
Global
From €953EUR$1,000USD£813GBP
Zoloft (sertraline) is a medication used to treat mental disorders such as depression, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and social anxiety disorder. It is a selective serotonin reuptake inhibitor (SSRI) and is one of the most commonly prescribed medications for these conditions. Zoloft is available in both generic and brand-name forms and is typically taken once daily.
The market for mental disorder drugs is highly competitive, with many different medications available to treat the same conditions. Zoloft is one of the most popular medications in this market, due to its effectiveness and relatively low side effects. It is also widely prescribed due to its availability in both generic and brand-name forms.
Some companies in the Zoloft market include Pfizer, GlaxoSmithKline, Mylan, and Teva Pharmaceuticals. Show Less Read more
